key: cord-0817933-jx9phhs7
authors: Clifford, Cole R.; Le May, Michel; Chow, Alyssa; Boudreau, Rene; Fu, Angel Y.N.; Barry, Quinton; Chong, Aun Yeong; So, Derek Y.F.
title: Delays in ST-Elevation Myocardial Infarction Care During the COVID-19 Lockdown: An Observational Study
date: 2020-12-15
journal: CJC Open
DOI: 10.1016/j.cjco.2020.12.009
sha: e28f9ddb8497001777abe07943dd40636f594ea0
doc_id: 817933
cord_uid: jx9phhs7

BACKGROUND: Management of ST-elevated myocardial infarction (STEMI) necessitates rapid reperfusion. Delays prolong myocardial ischemia and increase the risk of complications, including death. The COVID-19 pandemic may have impacted STEMI management. We evaluated the relative volume of hospitalizations and clinical time intervals within a regional STEMI system. METHODS: 494 patients with STEMI were grouped into pre-lockdown, lockdown and re-opening cohorts. Clinical, temporal and outcome data were collected and compared between groups for both urban and rural patients, receiving primary percutaneous coronary intervention (PCI) and pharmacoinvasive revascularization, respectively. Data was compared to a 10-year historical comparator. RESULTS: During pre-lockdown there was 238 cases versus 193 in lockdown; a 19.0% reduction in volume. When lockdown was compared to the median caseload from a 10-year historical cohort, a 19.8% reduction was observed. For patients treated with primary PCI during lockdown, median symptom-to-balloon time increased by 44-minutes [217 (IQR 157-387) vs. 261 (160-659) minutes; p=0.03]; driven by an increase in median symptom-to-door time of 41-minutes [136 (IQR 80-267) vs. 177 (IQR 90-569) minutes; p<0.01]. Only patients transferred from non-PCI facilities demonstrated an increase in door-to-reperfusion time [116 (IQR 93-150) vs. 139 (IQR 100-199) minutes; p<0.01]. More patients had left ventricular dysfunction during the lockdown [35% vs. 44%; p=0.04], but there was no difference in mortality. CONCLUSION: During the COVID-19 lockdown, fewer patients presented with STEMI. Time-to-reperfusion was significantly prolonged and appeared driven predominantly by patient-level and transfer delays. Public education and systems-level changes will be integral to STEMI care during the second wave of COVID-19.

During the COVID-19 pandemic, a reduction in patients presenting with ST-elevated myocardial infarction (STEMI) has been reported. 1, 2 These studies lacked data on important areas including: i) impact of the COVID-19 lockdown on STEMI care in regions with low disease incidence, ii) granular details regarding reperfusion management during lockdown, iii) effect of the pandemic on STEMI care in rural regions and iv) patterns of STEMI volume post COVID-19 lockdown. It is imperative to study the effects of COVID-19 comprehensively, such that lessons can be learned for a potential "second wave" or future pandemics.

From March 11 th , 2020 to August 16 th , 2020, the Ottawa regions recorded 2761 cases of COVID-19 and 267 COVID-19 related deaths. 3 In response to the initial outbreak, the Ontario Ministry of Health declared a state of emergency and instituted lockdown measures on March 17 th , 2020. 4 Various restrictions were imposed including closure of non-essential businesses, limits on social gatherings and cancellation of elective medical procedures. 4 These interventions were successful in limiting the spread of COVID-19; however, concerns regarding an unintended impact on STEMI care were raised. 3, 5 The University of Ottawa Heart Institute (UOHI) is the hub of STEMI care for the city of Ottawa and the surrounding Champlain region, a largely rural population. UOHI provides access to primary percutaneous coronary intervention (PCI) and pharmacoinvasive (PI) revascularization for patients presenting with STEMI in urban and rural settings, respectively. In anticipation of the COVID-19 lockdown, the UOHI STEMI and PCI protocols were extensively modified, due to potential changes in cardiac patient care. Accordingly, we set a comprehensive evaluation of STEMI volume and changes in critical time intervals, to determine the effects of the COVID-19 lockdown on STEMI management. J o u r n a l P r e -p r o o f

The UOHI STEMI program is a quaternary care dedicated-cardiac facility that is the regional hub for a high-volume STEMI program. It services over 1.3 million people, from both rural and urban communities, and treats over 700 STEMIs yearly. Due to its broad catchment area, the UOHI STEMI program includes patients managed with both primary percutaneous coronary intervention (pPCI) and pharmacoinvasive (PI) revascularization strategies. Patients presenting within approximately 100 kilometers may be transferred to the UOHI directly from the field or from a local emergency department for pPCI. Patients presenting beyond 100 km are managed with a PI approach and transferred immediately to the UOHI after receiving fibrinolytic therapy in the local emergency department. Once assessed and pre-loaded with antithrombotic medications, patients are taken to the cardiac catheterization laboratory for PCI. The UOHI STEMI program is subject to constant quality assurance investigation that tracks key timing metrics and in-hospital outcomes, permitting data collection for the present study.

During the COVID-19 pandemic, several changes were implemented at the STEMI program to maintain timely and safe care. Firstly, en-route to UOHI, a screening assessment patients' pre-test COVID-19 infection risk was performed. Secondly, 1 of the 4 cardiac catheterization laboratories was re-organized, suspended for use in elective cases and reserved only for COVID-19 suspected cases. Thirdly, the STEMI bay was relocated to an isolation room, where staff pre-donned in personal protective equipment (PPE) would await patient arrival and further assess COVID-19 risk. Patients at-risk for COVID-19 infections were triaged to the dedicated catherization laboratory, where staff were pre-donned with PPE. Lastly, a dedicated extra nurse was assigned to the COVID-19 catheterization laboratory to expedite flow.

Retrospective chart review of electronic medical records (EMR) was performed on consecutive patients presenting from November 15 th , 2019 to August 16 th , 2020. All patients with a discharge diagnosis of STEMI were analyzed. Patients were divided into 3 cohorts: "prelockdown" (Nov 15 th , 2019 to March 16 th , 2020), "lockdown" (March 17 th , 2020 to July 16 th , 2020) and "re-opening" (July 17 th , 2020 to August 16 th , 2020). The chosen time periods were based on the province's state of emergency and the regional phase 3 re-opening, when most public health restrictions were lifted. The timelines provide an equal 121-day period between the pre-lockdown and lockdown cohorts, as well as a 30-day sample of STEMI admissions after reopening. The UOHI STEMI database was queried for a "historical" cohort of patients admitted during the lockdown months between 2009-2019, to generate a comparator.

Key variables extracted and compared between cohorts include: 1) demographic and clinical characteristics 2) volume of STEMI admissions, 3) presentation characteristics 4) time metrics for patients by reperfusion strategies, and 5) in-hospital mortality and presence of left ventricular dysfunction (LVD) (defined by postinfarction transthoracic echocardiographic measurement of an ejection fraction of <50%). The historical cohort was used as a comparator for differences observed in the number of STEMI admissions and time metrics, in pPCI treated patients. For timeline comparison between the lockdown and historical cohorts, only patients that presented within 24 hours of symptom onset were included, as late presenters (>24hrs) were excluded in the UOHI pPCI STEMI database. Furthermore, the "door" times were re-adjusted based on ambulance off-loading of patients rather than EMR arrival times, in order to offer consistency with the historical data.

Normally distributed continuous variables are presented as mean +/-standard deviation.

Variables with a skewed distribution are presented as median and interquartile range (IQR).

Discrete variables are presented as frequencies. Normally distributed continuous variables were compared using student's t-test. Variables with a skewed distribution were compared using the Mann Whitney U-test. Discrete variables were compared using the Chi-squares test or Fisher's Exact test. A p-value <0.05 was considered statistically significant. Analysis was conducted using GraphPad Prism Version 8.4.3.

There were 238 and 193 STEMI admissions in the pre-lockdown and lockdown cohorts, respectively (Table 1) . This accounts for a 19.0% reduction in STEMI admissions during the lockdown. Baseline characteristics were similar, except less smokers and patients with a history of prior myocardial infarction presented during the lockdown. No differences were observed in the mode of transport to hospital, nor the initial facility of presentation (Table 2) . During the lockdown, 3 patients (2%) initially presented to a community-based COVID-19 testing center and were transferred to UOHI. In the lockdown cohort, 36 patients with STEMI were classified as "suspected" for COVID-19 infection. Of these, only one was diagnosed with laboratory confirmed COVID-19 infection. There were no differences in the strategies of revascularization between cohorts.

The distribution of cases over the entire study was U-shaped, with the nadir occurring March 17-April 16 and a rebound in volume with re-opening ( Figure 2 ). There was no difference J o u r n a l P r e -p r o o f in the decrease in volume between urban and rural patients. The distribution of cases in the historical cohort was steady, with little variation between months of presentation ( Figure 3A ).

There were decreases in STEMI volumes during the lockdown months, when compared to the historical cohort ( Figure 3A ) and a numerical trend for increasing STEMIs towards re-opening.

Overall, there was a 19.8% reduction in total STEMI admissions between the lockdown cohort and historical cohorts ( Figure 3B ).

Time intervals for reperfusion are shown in Table 3 

No difference was observed in the rates of in-hospital death [15 (6.3%) vs. 11 (5.7%); 

Our study evaluated STEMI care in a large region, with relatively low incidence of COVID-19, consisting of both urban and rural patients. The major findings included: i) A 19.0% and 19.8% reduction in STEMI admissions when comparing the lockdown cohort to the prelockdown and historical cohorts, respectively, ii) Reduction in volume was equal irrespective of urban or rural settings, iii) S2B time was increased during the lockdown, with a delay incurred predominantly by a prolonged S2D time; a trend consistent for urban and rural patients, iv) D2B times for transfer patients, but not patients triaged from the field, were increased during the COVID-19 pandemic, v) More patients presented with late infarctions, corresponding to an increase in postinfarction LVD during lockdown and vi) A return to pre-lockdown volume was observed with re-opening of the region.

Our study demonstrated a near 20% reduction in STEMI admissions during COVID-19.

Our reduction in STEMI volume is substantially smaller than the 40% drop seen in the United States of America (USA) and Spain. 6, 7 There was a vast discrepancy in COVID-19 incidence between Canada and the USA or Spain; yet there was still a marked decline in STEMI in our jurisdiction. This suggests that patient perception is a main driver for decreased STEMI volume, a trend that is further supported by documentation world-wide ( Figure 4 ). The reduction of STEMI admissions observed in Ottawa is similar to data from the province of Ontario, which demonstrated between a 18-25% reduction in STEMI cases. 1 The nadir of our STEMI admissions occurred between March 17 th -April 16 th , the period of peak COVID-19 incidence during the Ontario lockdown. Subsequently, the mean cases per month gradually rose into the reopening time period, when incident COVID-19 cases began to fall, and public health restrictions were lifted. In context with other literature, our data implies that both the incidence of COVID-J o u r n a l P r e -p r o o f 19 and resulting public health restrictions are important determinants of the reduction in STEMI cases observed. The decrease in volume is likely multifactorial. A main driver may be hesitancy of patients to seek medical attention for fear of contracting COVID-19. 8 The exact cause will not be elucidated; however, patients suffering STEMIs at home to avoid contracting COVID-19 is a major concern for a second wave of COVID-19.

Public health messaging regarding social distancing has been effective, as patients generally support "limiting in-person contact" and "staying at home". 9 However, concern arises if these attitudes are carried over to healthcare seeking behavior for acute illnesses, such as STEMI. A significant finding in our study is the incurred delay to reperfusion during the lockdown period. The basis of the delay to treatment appeared attributable to patients presenting late after symptom onset, resulting in an increase in LVD, during the lockdown. This is of particular concern as patients presenting with late STEMIs have larger infarcts and are known to have higher incidence of heart failure and worse long-term outcomes. 10, 11 Our observed increase in S2D time is in keeping with findings in other studies. [12] [13] [14] Early analysis of emergency department admissions during COVID-19 suggest patients fear contracting COVID-19 at the hospital and are unclear when to present for medical care. 8 Notably, several of our STEMI patients during the lockdown presented directly to community COVID-19 swab centres, with the impression that their symptoms were due to COVID-19. All of this supports the importance of public education on the dangers of avoiding seeking medical attention and the need to inform the public on symptoms of myocardial infarction. 15 With the anticipated second wave of COVID-19 and possible repeat lockdowns, it is imperative that public service announcements and associated strategies be considered by health agencies now.

J o u r n a l P r e -p r o o f COVID-19 overwhelmed healthcare systems, leading some interventional cardiologists to propose a switch to fibrinolytics, as a first-line approach to STEMI reperfusion. 16, 17 Current guidelines in the province of Ontario advocate maintaining a pPCI approach during COVID-19. 19 A previous Ontario-wide study of pPCI during COVID-19 showed increases in D2B times for patients triaged from the field, however our study did not 1 . This is likely based on the preemptive modifications to our system to avoid delays. We did observe an increase in D2B time for patients transferred for pPCI and PI revascularization patients, suggesting potential delays in non-cardiac facility triaging systems and transfer protocols during the COVID-19 lockdown.

Adaptation of the approach to STEMI triage at our institution and further amendments to transfer systems may help reduce hospital-level delays in STEMI care, especially if emergency medical services resources are strained during a second wave of COVID-19.

Our study has several limitations. Firstly, we report data from a single cardiac-center, so our study is reflective of the local STEMI program. However, our results are consistent to Ontario-wide data, which suggests that our findings are generalizable. Furthermore, our STEMI program services a large geographic area consisting of both urban and rural surrounding communities; thus, providing data not reported in previous studies. Additionally, due to the retrospective nature of our study, not all patients had complete clinical information. This resulted in 8 out of 454 potential patients being excluded for the timeline analysis, as their complete clinical timeline could not be verified. This amounts to only a 2% exclusion rate and therefore unlikely to affect findings. Lastly, our study does not establish definitive causality for decrease in volumes or delays.

In summary, we demonstrated a 19.0% reduction in STEMI cases during COVID-19 lockdown.

Time-to-reperfusion was significantly prolonged, with a predominant driver being patient related factors and transfer delays. Public education and systems-level change will be integral to STEMI care during a second wave of COVID-19. minutes. *Denotes significant difference (p<0.05) between "Lockdown" and "Pre-Lockdown" groups. cases, the cases per million, the drop in STEMI volume by percentages and the size of the study

Early Observations during COVID-19 pandemic in cardiac catheterization procedures for ST Elevation Myocardial Infarctions (STEMI) across Ontario. CJC Open

Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease

COVID-19 -Guidance for the Health Sector -Ministry Programs -Health Care Professionals -MOH

COVID-19-Where Have All the STEMIs Gone?

Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic

Impact of the COVID-19 pandemic on interventional cardiology activity in Spain

Where Are All the Patients? Addressing Covid-19 Fear to Encourage Sick Patients to Seek Emergency Care

Public Attitudes, Behaviors, and Beliefs Related to COVID-19, Stay-at-Home Orders, Nonessential Business Closures, and Public Health Guidance -United States

Very late presentation in ST elevation myocardial infarction: Predictors and long-term mortality

Symptom-to-door time in ST segment elevation myocardial infarction: Overemphasized or overlooked? Results from the AMI-McGill study

Decrease in acute coronary syndrome presentations during the COVID-19 pandemic in upstate New York

ST-Segment-Elevation Myocardial Infarction During COVID-19 Pandemic: Insights From a Regional Public Service Healthcare Hub

Impact of COVID-19 outbreak and public lockdown on ST-elevation myocardial infarction care in Spain

Variation and Disparities in Awareness of Myocardial Infarction Symptoms Among Adults in the United States

ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy

Reperfusion of ST-segment-elevation myocardial infarction in the COVID-19 Era: Business as usual? Circulation

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials

Recommendations for an Ontario Approach to Managing STEMI during COVID-19

Assessment of ST-Segment Elevation Myocardial Infarction Volume Trends During The COVID-19 Pandemic

Single Center Trends in Acute Coronary Syndrome Volume and Outcomes During the COVID-19 Pandemic

Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States

Impact of COVID-19 pandemic on STelevation myocardial infarction in a non-COVID-19 epicenter

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

Emergency Calling in COVID-19 Outbreak

COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England

Patients response, treatments and mortality for acute myocardial infarction during the COVID-19 pandemic

Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: Insights from a British cardiac center

Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction

COVID-19 and STEMI: A snapshot analysis of presentation patterns during a pandemic

Impact of COVID-19-related public containment measures on the ST elevation myocardial infarction epidemic in Belgium: a nationwide, serial, cross-sectional study

Missing" acute coronary syndrome hospitalizations during the COVID-19 era in Greece: Medical care avoidance combined with a true reduction in incidence?

Impact of COVID-19 outbreak on regional STEMI care in Germany

31 days of COVID-19-cardiac events during restriction of public life-a comparative study

STEMI and COVID-19 Pandemic in Saudi Arabia

Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage

Effect of the COVID-19 Pandemic on Treatment Delays in Patients with ST-Segment Elevation Myocardial Infarction

Impact of coronavirus disease 2019 (COVID-19) outbreak on outcome of myocardial infarction in Hong Kong, China

Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China

Decreases in cardiac catheter laboratory workload during the COVID-19 level 4 lockdown in New Zealand

For the contemporary group, patients with >24hrs of chest pain were excluded and "door time" for lockdown period adjusted to ambulance unloading time versus electronic medical record registration time, allowing direct comparison with historical data. The historical cohort represents STEMI patients presenting from 2009-2019 over the same time periods of the lockdown cohort. Symptom to door time is defined as time from onset of chest pain to presentation at first medical facility. Door to balloon time is defined as time from presentation to medical facility and reperfusion across culprit lesion. Symptom to balloon time is defined as the time from chest pain onset to reperfusion across culprit lesion. All times are quantified in minutes. *Denotes significant difference (p<0.05) between lockdown and historical control cohort